Rajnish Wellness Ltd (RAJNISH) — shareholding pattern, promoter holding, financials and share price
About Rajnish Wellness Ltd (RAJNISH)
Rajnish Wellness Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as RAJNISH and on the BSE under scrip code 541601. Its ISIN is INE685Z01033.
Incorporated in 2015, Rajnish Wellness Ltd manufactures and sells various ayurvedic medicinal products. [1]
Rajnish Wellness Limited, originally incorporated in 2015, focuses on selling consumer durables and ayurvedic personal care products, with an emphasis on sexual wellness and energy revitalization.
The company exploits a competitive price advantage by targeting Tier I, II, and III markets mainly across several Indian states including Maharashtra, Uttar Pradesh, and Karnataka.
Listed peers in Pharmaceuticals: Shelter Pharma Ltd, Vista Pharmaceuticals Ltd, Mangalam Drugs and Organics Ltd, ANG Lifesciences India Ltd, Sandu Pharmaceuticals Ltd.
Valuation & Returns
10 Jul 2026At ₹0.41 a share on 10 Jul 2026, Rajnish Wellness Ltd (RAJNISH) was valued at a price-to-earnings ratio of -7.81x against an industry P/E of 36.41x and a price-to-book of 0.49x on a book value of ₹0.83 per share as of Mar 2025. Solomo computes return on equity of -6.33% and return on capital employed of -8.83% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- -7.81x
- Industry P/E
- 36.41x
- P/B
- 0.49x
- EPS (TTM)
- ₹-0.05
- Book value / share
- ₹0.83
- ROE
- -6.33%
- ROCE
- -8.83%
- ROA
- -5.84%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- -5.25%
- 52-week range
- ₹0.39 – ₹1.26
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Rajnish Wellness Ltd (RAJNISH) reported revenue of ₹142 crore, net profit of ₹-6 crore and earnings per share of ₹-0.06. That compares with revenue of ₹49 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹101.95 crore and net profit ₹-4.7 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 26 | 26 | 77 | 49 | 142 |
| Net profit (₹ cr) | 0 | 0 | 1 | 0 | -6 |
| EPS (₹) | 0.01 | 0 | 0.01 | 0 | -0.06 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 15.61% | 28.71% | 22.47% | -36.67% |
| Profit growth | -6.72% | - | -23.86% | -83.50% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 9.16% of Rajnish Wellness Ltd (RAJNISH) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.43%. Market capitalisation was ₹42 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2018.
Largest disclosed public shareholders in Jun 2026: JR SEAMLESS PRIVATE LIMITED 1.3%, GURCHARAN SINGH CHANDHOK 1.13%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 9.16% | - | 0.43% | - | 90.84% |
| Mar 2026 | 9.16% | - | 0.43% | - | 90.84% |
| Dec 2025 | 9.16% | - | 0.43% | - | 90.84% |
| Sep 2025 | 9.16% | - | 0.43% | - | 90.84% |
| Jun 2025 | 7.41% | - | 0.57% | - | 92.59% |
| Mar 2025 | 7.41% | - | 0.57% | - | 92.59% |
| Dec 2024 | 7.41% | - | - | - | 92.59% |
| Sep 2024 | 16.24% | - | 0.2% | - | 83.76% |